Importantly, post-ischemic CTMP siRNA treatment, as late as 2 h after the onset of reperfusion, could also significantly reduced infarct volume (Figure 6D), suggesting the possibility for CTMP as a therapeutic target for stroke. This evidence concerns the gene THEM4 and Stroke.